Combination Therapy: Safety and Clinical Considerations When HRT and GLP-1 therapies are used together, the primary challenge shifts from isolated risk management to integrated physiologic balance
On GLP-1 medications, your appetite cues will likely change
During the 80-week trial, participants lost an average of 28 percent of their body weight (roughly 70 pounds) on the highest dose of retatrutide, while nearly half shed 30 percent of their weight or more
Exosome and growth-factor therapies derived from mesenchymal stem cells, which are being studied for their ability to stimulate dermal papilla cells, activate hair follicle stem cells, and promote local angiogenesis
After overnight fasting, animals received PBS or test compounds (Semaglutide, Tirzepatide, or Retatrutide) in the morning, and food was provided 15 minutes post-dosing
Dose titration represents the most important preventative strategy